Drug Eluting Balloon Market Will be Worth US$ 1800 Mn by 2026

Drug Eluting Balloon Market - Snapshot

Drug eluting balloon is a semi-compliant angioplasty balloon, coated with anti-proliferative medicine. The medicine is ejected to the vessel walls during the inflation of the balloon. The balloons are inflated through application of nominal pressure. The active substance of the balloon is highly lipophilic in nature. Drug eluting balloon homogeneously delivers the drug to the vessel and prevents neointimal hyperplasia (proliferation of vascular smooth muscle and thickening of arterial wall, thus reducing the arterial lumen space). The device has gained popularity as it helps in effective treatment of in-stent restenosis as compared to drug eluting stent or bare metal stent. Rise in peripheral and coronary artery diseases among the geriatric population is likely to drive the global drug eluting balloon market in the near future.

Browse Press Release @

https://www.transparencymarketresearch.com/pressrelease/drug-eluting-balloons-market.htm

The global drug eluting balloon market is characterized by increase in incidence of peripheral artery diseases (PAD) across the world. The market is witnessing gradual rise in research and development activities supported by government policies. The global drug eluting balloon market was valued at US$ 420 Mn in 2017 and is projected to reach US$ 1800 Mn in 2026, expanding at a CAGR of 18% from 2018 to 2026.

Request for Sample Copy of Report @

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2321

Growth in geriatric population, which is prone to cardiovascular diseases, large patient base in developing countries demanding proper treatment, and investments made by public and private market players in R&D on drug eluting balloon for treatment of peripheral and coronary artery diseases are the major factors driving the global drug eluting balloon market. However, lengthy regulatory approval procedure, significant investment required due to high attrition rate in clinical trials, and adverse effects such as coronary artery lesion and lumen enlargement are likely to restrain the growth of the global drug eluting balloon market during the forecast period. Drug eluting balloon are gaining popularity among surgeons as they have proved effective in the treatment of peripheral artery and coronary artery diseases. Use of drug eluting balloon reduces the risk of stent failure and are found to be more effective in the treatment of superficial femoral artery (SFA) lesions than drug eluting stents or bare metal stents. Investment in R&D for drug eluting balloon and partnerships for co-development and commercialization of anti-infective agents are expected to fuel the growth of the global drug eluting balloon market in the near future.

Request Report Brochure @

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2321

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research

State Tower,

90 State Street, Suite 700

Albany, NY 12207

United States

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: www.transparencymarketresearch.com

My name is Pragya Tripathi and I work with the Digital Marketing and Editorial team of Transparency Market Research, a market intelligence firms based in India & Usa.